This is a StreetInsider.com Premium Only Page

Surface Oncology (SURF) – StreetInsider.com Reports

Aug 31, 2023 04:01 PM Surface Oncology (SURF) Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences (CHRS)

Jun 20, 2023 06:37 AM H.C. Wainwright Downgrades Surface Oncology (SURF) to Neutral

Jun 20, 2023 12:55 AM Baird Downgrades Surface Oncology (SURF) to Neutral

Jun 19, 2023 05:56 AM Wedbush Downgrades Surface Oncology (SURF) to Neutral

Jun 16, 2023 07:05 AM Coherus (CHRS) to Acquire Surface Oncology (SURF)

Jun 16, 2023 06:57 AM Surface Oncology (SURF) Halted, News Pending

Apr 18, 2023 07:00 AM Surface Oncology (SURF) Presents New Preclinical Data on SRF114

Nov 3, 2022 06:41 AM Surface Oncology (SURF) PT Lowered to $6 at Baird

Nov 3, 2022 06:31 AM Surface Oncology (SURF) PT Lowered to $6 at H.C. Wainwright

Nov 2, 2022 04:42 PM Surface Oncology (SURF) PT Lowered to $3 at Wedbush

Nov 2, 2022 06:31 AM Surface Oncology (SURF) Announces Promising SRF388 Monotherapy Data

Oct 19, 2022 07:03 AM Surface (SURF) and VIB Report Publication in Cell Reports Revealing IL-27 Structure and the Mechanism of Action for SRF388

Aug 8, 2022 06:40 AM Surface Oncology (SURF) PT Lowered to $8.50 at H.C. Wainwright

Jun 29, 2022 07:02 AM Surface Oncology (SURF) Appoints Carsten Brunn to its Board

May 26, 2022 05:06 PM Surface Oncology (SURF) to Present New SRF388 Clinical Data at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

May 10, 2022 05:51 AM Surface Oncology (SURF) PT Lowered to $12 at BTIG

May 9, 2022 07:10 AM Surface Oncology (SURF) Reports Q1 EPS of $0.13, Provides Corporate Highlights

Apr 8, 2022 04:02 PM Surface Oncology (SURF) Presents New SRF388 Data

Mar 31, 2022 07:32 AM Surface Oncology (SURF) Achieves $30 Million Milestone with First Patient Dosed in GlaxoSmithKline Phase 1 Study

Mar 2, 2022 07:11 AM Surface Oncology (SURF) Reports Q4

Dec 15, 2021 07:06 AM Surface Oncology (SURF) Appoints Denice Torres as Board Chair, Announces 2 New Directors

Dec 6, 2021 09:31 AM Surface Oncology (SURF) Reports Promising Clinical Data on SRF617

Dec 1, 2021 07:03 AM Surface Oncology (SURF) Announces FDA Clearance of IND Application for GSK4381562, a Novel Antibody Targeting PVRIG

Sep 29, 2021 06:53 AM Cathie Wood's ARK Sold Another $265M in Tesla (TSLA) Stock on Tuesday

Sep 20, 2021 10:17 AM Increasing unusual call option volume: SURF YANG TMC LIDR VSTM HIPO ATER CRNT

Sep 20, 2021 08:44 AM Positive Combo Data at ESMO Offers Positive Readthroughs to Surface Oncology (SURF) Adenosine Pathway Assets - BTIG

Aug 5, 2021 04:15 PM Surface Oncology (SURF) PT Lowered to $14 at Wedbush, Following Earnings

Jul 8, 2021 07:09 AM Surface Oncology (SURF) Appoints Denice Torres to Board of Directors

Jun 4, 2021 07:05 AM Surface Oncology (SURF) Announces SRF388 Demonstrates Monotherapy Activity in Data Presented at American Society of Clinical Oncology Annual Meeting

Jun 4, 2021 07:02 AM Surface Oncology (SURF) to Collaborate with Roche on Immuno-Oncology Study Evaluating SRF388, Targeting IL-27, as Part of a Novel Combination in Patients with Advanced Treatment-naïve Hepatocellular

May 17, 2021 04:27 PM UPDATE: BTIG Starts Surface Oncology (SURF) at Buy

Apr 27, 2021 07:12 AM Surface Oncology (SURF) names Henry Rath as chief business officer, Alison O’Neill as chief medical officer and Jessica Fees as chief financial officer

Apr 9, 2021 07:54 AM Surface Oncology (SURF) Presents Promising Preclinical Data for Lead Immunotherapy Product Candidates at AACR

Mar 31, 2021 09:22 AM Pre-Open Stock Movers 03/31: (SURF) (CHWY) (CASI) Higher; (DCTH) (RMO) (CLSN) Lower (more...)

Mar 30, 2021 05:42 PM After-Hours Stock Movers 03/30: (SURF) (CASI) (CHWY) Higher; (NMTR) (OSMT) (BB) Lower (more...)

Mar 30, 2021 04:30 PM Surface Oncology's (SURF) SRF617 Receives Orphan Drug Designation from FDA for Treatment of Pancreatic Cancer

Mar 29, 2021 03:57 PM Surface Oncology (SURF) Ticks Higher on FDA Orphan Drug Designation for ?-cd39 Igg4 Monoclonal Antibody

Mar 18, 2021 10:19 AM Surface Oncology (SURF) call put ratio 30 calls to 1 put

Mar 17, 2021 11:31 AM Options with increasing option implied volatility: NKE FDX STLA AJAX NLY SURF

Mar 17, 2021 10:42 AM Surface Oncology (SURF) call put ratio 15.8 calls to 1 put as shares rally 5.4%

Mar 17, 2021 10:40 AM Surface Oncology (SURF) on Watch ARK Chatter

Mar 9, 2021 09:26 AM Pre-Open Stock Movers 03/09: (EYES) (TRIT) (SURF) Higher; (ACAD) (SFIX) (WTRH) Lower (more...)

Mar 9, 2021 07:02 AM Surface Oncology (SURF) to Collaborate with Merck (MRK) on Immuno-Oncology Study Evaluating SRF388, Targeting IL-27, in Combination with KEYTRUDA in Patients with Solid Tumors

Feb 23, 2021 06:51 AM Cathie Wood's ARK Bought Buys ~$200M More Tesla (TSLA) Monday on Sell-Off

Feb 22, 2021 08:32 AM Vaccinex Announces Licensing of Anti-CCR8 Antibody to Surface Oncology (SURF)

Feb 11, 2021 07:19 AM Surface Oncology (SURF) to Appoint Robert Ross, M.D., as President and Chief Executive Officer

Dec 18, 2020 07:02 AM Surface Oncology (SURF) PT Raised to $15 at H.C. Wainwright

Dec 17, 2020 03:58 PM Surface Oncology (SURF) PT Raised to $18 at Wedbush

Dec 17, 2020 07:06 AM Surface Oncology (SURF) Enters License Agreement with GSK, $85M Upfront and Up to $730M in Milestones

Nov 13, 2020 07:10 AM Surface Oncology (SURF) Announces SRF617 and SRF388 Will Advance to Combination and Expansion Stages of Ongoing Phase 1 Clinical Trials